Python has become one of the most popular programming languages out there, particularly for beginners and those new to the hacker/maker world. Unfortunately, while it’s easy to get something up and ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

BLOOM (TAMPA)- On this episode of Bloom Health Club presented by Monticciolo Family & Sedation Dentistry, host Gayle Guyardo welcomes Brain Injury Expert Dr. Joseph Dituri, also known as Dr. Deep Sea, ...

Package Python apps for easy delivery as executables, dig into Python 3.14's new debugging interface, and get live coding help for making sense of datasets. Want extra credit? Try wrangling Python ...

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Nvidia made early investors rich, but there is a new class ...

In our polarized politics, a 99–1 Senate vote is a very odd duck. Odder still is the fact that this particular vote—on artificial intelligence regulation, a topic of immense strategic ...

The company laid out its restructuring plans in a regulatory document. These include a workforce reduction of around 20%. Before market open, Recursion disclosed in a tersely worded regulatory filing ...

The results of a recent survey released Tuesday showed President Trump's actions are likely to make it harder for biotech companies like Recursion to raise capital. The company reported ...

Recursion said it will end development for four of its 11 pipeline programs—one of which the company will consider outlicensing to a partner instead—and pause a fifth program, in a pruning designed to ...

Recursion Pharmaceuticals is a pioneer in AI-powered drug discovery but faces challenges in monetizing its innovations and aligning management's vision with sustainable revenue paths. The company's ...